Prosight Management
Latest statistics and disclosures from Prosight Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are PCRX, HUM, GLPG, MGTX, KURA, and represent 41.72% of Prosight Management's stock portfolio.
- Added to shares of these 10 stocks: MGTX (+$13M), GLPG (+$11M), PCRX (+$10M), INSP (+$7.9M), MDT (+$7.1M), DXCM (+$5.8M), KURA (+$5.4M), UHS (+$5.1M), HUM, MASI.
- Started 11 new stock positions in DSGN, CHE, ZYME, INSP, DXCM, EOLS, UHS, PEN, MASI, BMEA. BBSI.
- Reduced shares in these 10 stocks: MIRM (-$10M), NBIX (-$10M), CNC (-$8.0M), , MRVI, ERAS, ALKS, LBPH, QDEL, Trinet Group Inc cmn.
- Sold out of its positions in ALDX, Aldeyra Therapeutics, MRVI, MODV, TOI, Trinet Group Inc cmn, UNH.
- Prosight Management was a net buyer of stock by $35M.
- Prosight Management has $316M in assets under management (AUM), dropping by -3.15%.
- Central Index Key (CIK): 0001617201
Tip: Access up to 7 years of quarterly data
Positions held by Prosight Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Prosight Management
Prosight Management holds 41 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Pacira Pharmaceuticals (PCRX) | 11.8 | $37M | +37% | 1.2M | 30.68 |
|
| Humana (HUM) | 10.0 | $32M | +17% | 65k | 486.52 |
|
| Galapagos Nv Spon Adr (GLPG) | 8.0 | $25M | +74% | 730k | 34.55 |
|
| Meiragtx Holdings (MGTX) | 6.3 | $20M | +193% | 4.1M | 4.91 |
|
| Kura Oncology (KURA) | 5.6 | $18M | +43% | 1.9M | 9.12 |
|
| BioCryst Pharmaceuticals (BCRX) | 5.4 | $17M | -3% | 2.4M | 7.08 |
|
| Oric Pharmaceuticals (ORIC) | 4.9 | $16M | -6% | 2.6M | 6.05 |
|
| Medtronic SHS (MDT) | 3.7 | $12M | +150% | 150k | 78.36 |
|
| Abcellera Biologics (ABCL) | 3.6 | $11M | -4% | 2.4M | 4.60 |
|
| Mirum Pharmaceuticals (MIRM) | 3.5 | $11M | -47% | 354k | 31.60 |
|
| Neurocrine Biosciences (NBIX) | 2.9 | $9.0M | -52% | 80k | 112.50 |
|
| Inari Medical Ord (NARI) | 2.7 | $8.5M | +9% | 130k | 65.40 |
|
| Inspire Med Sys (INSP) | 2.5 | $7.9M | NEW | 40k | 198.44 |
|
| Option Care Health Com New (OPCH) | 2.3 | $7.1M | -6% | 220k | 32.35 |
|
| Quidel Corp (QDEL) | 2.0 | $6.2M | -23% | 85k | 73.04 |
|
| Prothena Corp SHS (PRTA) | 1.9 | $6.1M | +5% | 126k | 48.25 |
|
| Nanostring Technologies (NSTGQ) | 1.9 | $5.9M | +72% | 3.4M | 1.72 |
|
| Dex (DXCM) | 1.8 | $5.8M | NEW | 62k | 93.30 |
|
| Kezar Life Sciences (KZR) | 1.8 | $5.7M | +2% | 4.8M | 1.19 |
|
| Centene Corporation (CNC) | 1.7 | $5.5M | -59% | 80k | 68.88 |
|
| Universal Hlth Svcs CL B (UHS) | 1.6 | $5.1M | NEW | 41k | 125.73 |
|
| Adc Therapeutics Sa SHS (ADCT) | 1.5 | $4.8M | -3% | 5.4M | 0.90 |
|
| Teladoc (TDOC) | 1.5 | $4.6M | +225% | 250k | 18.59 |
|
| Masimo Corporation (MASI) | 1.1 | $3.5M | NEW | 40k | 87.68 |
|
| Graphite Bio | 1.1 | $3.3M | -21% | 1.3M | 2.48 |
|
| Irhythm Technologies (IRTC) | 1.0 | $3.3M | -2% | 35k | 94.26 |
|
| Penumbra (PEN) | 1.0 | $3.3M | NEW | 14k | 241.91 |
|
| Shattuck Labs (STTK) | 1.0 | $3.2M | 2.1M | 1.52 |
|
|
| Design Therapeutics (DSGN) | 0.9 | $2.8M | NEW | 1.2M | 2.36 |
|
| Barrett Business Services (BBSI) | 0.6 | $1.9M | NEW | 21k | 90.24 |
|
| Compass Therapeutics (CMPX) | 0.6 | $1.8M | -13% | 935k | 1.97 |
|
| Alkermes SHS (ALKS) | 0.6 | $1.8M | -55% | 65k | 28.01 |
|
| Longboard Pharmaceuticals In (LBPH) | 0.6 | $1.8M | -56% | 321k | 5.56 |
|
| Nuvation Bio Com Cl A (NUVB) | 0.4 | $1.4M | -4% | 1.1M | 1.34 |
|
| Agilon Health (AGL) | 0.4 | $1.4M | -20% | 79k | 17.76 |
|
| Biomea Fusion (BMEA) | 0.4 | $1.3M | NEW | 95k | 13.76 |
|
| Chemed Corp Com Stk (CHE) | 0.4 | $1.3M | NEW | 2.5k | 519.70 |
|
| Evolus (EOLS) | 0.4 | $1.2M | NEW | 127k | 9.14 |
|
| Zymeworks Del (ZYME) | 0.2 | $675k | NEW | 106k | 6.34 |
|
| Erasca (ERAS) | 0.2 | $522k | -83% | 265k | 1.97 |
|
| Elutia Cl A Com (ELUT) | 0.0 | $37k | -92% | 26k | 1.43 |
|
Past Filings by Prosight Management
SEC 13F filings are viewable for Prosight Management going back to 2017
- Prosight Management 2023 Q3 filed Nov. 14, 2023
- Prosight Management 2023 Q2 filed Aug. 14, 2023
- Prosight Management 2023 Q2 restated filed Aug. 14, 2023
- Prosight Management 2023 Q1 filed May 12, 2023
- Prosight Management 2022 Q4 filed Feb. 14, 2023
- Prosight Management 2022 Q3 filed Nov. 14, 2022
- Prosight Management 2022 Q2 filed Aug. 12, 2022
- Prosight Management 2022 Q1 filed May 16, 2022
- Prosight Management 2021 Q4 filed Feb. 14, 2022
- Prosight Management 2021 Q3 filed Nov. 12, 2021
- Prosight Management 2021 Q2 filed Aug. 13, 2021
- Prosight Management 2021 Q1 filed May 14, 2021
- Prosight Management 2020 Q4 filed Feb. 12, 2021
- Prosight Management 2020 Q3 filed Nov. 13, 2020
- Prosight Management 2020 Q2 filed Aug. 14, 2020
- Prosight Management 2020 Q1 filed May 15, 2020